These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1135 related articles for article (PubMed ID: 7805002)

  • 1. Medical management of stage IV malignant melanoma. Medical issues.
    Ho RC
    Cancer; 1995 Jan; 75(2 Suppl):735-41. PubMed ID: 7805002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of metastatic melanoma: an overview.
    Bhatia S; Tykodi SS; Thompson JA
    Oncology (Williston Park); 2009 May; 23(6):488-96. PubMed ID: 19544689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapies in the treatment of stage II and III malignant melanoma.
    Kavanagh D; Hill AD; Djikstra B; Kennelly R; McDermott EM; O'Higgins NJ
    Surgeon; 2005 Aug; 3(4):245-56. PubMed ID: 16121769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of metastasized malignant melanoma].
    Kamanabrou D
    Praxis (Bern 1994); 2001 Mar; 90(10):391-6. PubMed ID: 11305184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.
    Sznol M; Clark JW; Smith JW; Steis RG; Urba WJ; Rubinstein LV; VanderMolen LA; Janik J; Sharfman WH; Fenton RG
    J Natl Cancer Inst; 1992 Jun; 84(12):929-37. PubMed ID: 1629914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant immunotherapy in melanoma with irradiated autologous tumor cells and low dose cyclophosphamide.
    Elias EG; Suter CM; Fabian DS
    J Surg Oncol; 1997 Jan; 64(1):17-22. PubMed ID: 9040795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic therapy in disseminated melanoma.
    Rümke PH
    Semin Surg Oncol; 1992; 8(6):392-9. PubMed ID: 1279776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the care of the patient with malignant melanoma.
    Reintgen D; Balch CM; Kirkwood J; Ross M
    Ann Surg; 1997 Jan; 225(1):1-14. PubMed ID: 8998115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjuvant adoptive immunotherapy in patients with stage III and resected stage IV melanoma: a pilot study].
    Verdecchia GM; Ridolfi L; Ridolfi R; Riccobon A; Bertagni A; Vagliasindi A; Petrini M; Stefanelli M; Milandri C; Amadori D
    Tumori; 2003; 89(4 Suppl):298-300. PubMed ID: 12903626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis.
    Teulings HE; Limpens J; Jansen SN; Zwinderman AH; Reitsma JB; Spuls PI; Luiten RM
    J Clin Oncol; 2015 Mar; 33(7):773-81. PubMed ID: 25605840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.
    Sasse AD; Sasse EC; Clark LG; Ulloa L; Clark OA
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005413. PubMed ID: 17253556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma.
    Meisenberg BR; Ross M; Vredenburgh JJ; Jones R; Shpall EJ; Seigler HF; Coniglio DM; Wu K; Peters WP
    J Natl Cancer Inst; 1993 Jul; 85(13):1080-5. PubMed ID: 8515495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adjuvant therapy in melanoma management.
    Barth A; Morton DL
    Cancer; 1995 Jan; 75(2 Suppl):726-34. PubMed ID: 7805001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose adjuvant interferon for stage III malignant melanoma.
    Inman JL; Russell GB; Savage P; Levine EA
    Am Surg; 2003 Feb; 69(2):127-30. PubMed ID: 12641352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of melanoma].
    Dréno B; Wallon-Dumont G
    Presse Med; 2003 Jan; 32(1):39-43. PubMed ID: 12610396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanoma.
    Okwan-Duodu D; Pollack BP; Lawson D; Khan MK
    Am J Clin Oncol; 2015 Feb; 38(1):119-25. PubMed ID: 23648438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current therapy for malignant melanoma.
    Legha SS
    Semin Oncol; 1989 Feb; 16(1 Suppl 1):34-44. PubMed ID: 2465575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic treatments for advanced cutaneous melanoma.
    Anderson CM; Buzaid AC; Legha SS
    Oncology (Williston Park); 1995 Nov; 9(11):1149-58; discussion 1163-4, 1167-8. PubMed ID: 8703684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving survival in patients with high-risk and metastatic melanoma: immunotherapy leads the way.
    Agarwala S
    Am J Clin Dermatol; 2003; 4(5):333-46. PubMed ID: 12688838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic malignant melanoma associated with vitiligo-like depigmentation.
    Wang JR; Yu KJ; Juan WH; Yang CH
    Clin Exp Dermatol; 2009 Mar; 34(2):209-11. PubMed ID: 18691245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.